{"created_at":"Fri Mar 06 16:39:25 +0000 2015","id":573885607073701888,"id_str":"573885607073701888","text":"RT @FiercePharma: Novartis gets bragging rights on first U.S. biosim. But will its Neupogen copy sell? http:\/\/t.co\/4CdGqMeuAM $NVS  #pharma\u2026","source":"\u003ca href=\"http:\/\/twitter.com\/download\/iphone\" rel=\"nofollow\"\u003eTwitter for iPhone\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":237929579,"id_str":"237929579","name":"Artu.ro.Olg.uin","screen_name":"ChartyBoy","location":"New York City, NY","url":null,"description":"Amateur actor\/writer with a Masters in Biotechnology from Columbia University","protected":false,"verified":false,"followers_count":65,"friends_count":188,"listed_count":3,"favourites_count":288,"statuses_count":1974,"created_at":"Thu Jan 13 23:50:26 +0000 2011","utc_offset":null,"time_zone":null,"geo_enabled":true,"lang":"es","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/1215005214\/me_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/1215005214\/me_normal.png","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/237929579\/1378747425","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Fri Mar 06 15:24:11 +0000 2015","id":573866672668438528,"id_str":"573866672668438528","text":"Novartis gets bragging rights on first U.S. biosim. But will its Neupogen copy sell? http:\/\/t.co\/4CdGqMeuAM $NVS  #pharma by @CarlyHFierce","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":18294275,"id_str":"18294275","name":"FiercePharma","screen_name":"FiercePharma","location":"West End, District of Columbia","url":"http:\/\/www.fiercepharma.com","description":"FiercePharma's 140, written by Tracy Staton. Join 90,000 pharma insiders on our free newsletter at http:\/\/FiercePharma.com.","protected":false,"verified":false,"followers_count":38816,"friends_count":466,"listed_count":1170,"favourites_count":9,"statuses_count":16692,"created_at":"Sun Dec 21 22:25:49 +0000 2008","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"060932","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"DA490B","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDFFCC","profile_text_color":"080707","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2579243072\/qooxzvtqfq9bj6kkhllk_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2579243072\/qooxzvtqfq9bj6kkhllk_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":5,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[114,121]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/4CdGqMeuAM","expanded_url":"http:\/\/www.fiercepharma.com\/story\/novartis-gets-bragging-rights-first-us-biosim-will-its-neupogen-copy-sell\/2015-03-06","display_url":"fiercepharma.com\/story\/novartis\u2026","indices":[85,107]}],"user_mentions":[{"screen_name":"CarlyHFierce","name":"Carly Helfand","id":1379301222,"id_str":"1379301222","indices":[125,138]}],"symbols":[{"text":"NVS","indices":[108,112]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"pharma","indices":[132,139]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/4CdGqMeuAM","expanded_url":"http:\/\/www.fiercepharma.com\/story\/novartis-gets-bragging-rights-first-us-biosim-will-its-neupogen-copy-sell\/2015-03-06","display_url":"fiercepharma.com\/story\/novartis\u2026","indices":[103,125]}],"user_mentions":[{"screen_name":"FiercePharma","name":"FiercePharma","id":18294275,"id_str":"18294275","indices":[3,16]},{"screen_name":"CarlyHFierce","name":"Carly Helfand","id":1379301222,"id_str":"1379301222","indices":[139,140]}],"symbols":[{"text":"NVS","indices":[126,130]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1425659965662"}
{"created_at":"Fri Mar 06 19:59:43 +0000 2015","id":573936014223241216,"id_str":"573936014223241216","text":"@PinkSheetSutter $NVS Your tweet has been featured on Market Parse, for iPhone. http:\/\/t.co\/YHInvBCk4m","source":"\u003ca href=\"http:\/\/www.marketparse.com\" rel=\"nofollow\"\u003eMarket Parse\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":155916518,"in_reply_to_user_id_str":"155916518","in_reply_to_screen_name":"PinkSheetSutter","user":{"id":3005559517,"id_str":"3005559517","name":"Market Parse","screen_name":"MarketParse","location":"San Francisco","url":"http:\/\/www.marketparse.com","description":"Investment news simplified","protected":false,"verified":false,"followers_count":976,"friends_count":2001,"listed_count":36,"favourites_count":147,"statuses_count":35536,"created_at":"Sat Jan 31 23:23:53 +0000 2015","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"000000","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"3B94D9","profile_sidebar_border_color":"000000","profile_sidebar_fill_color":"000000","profile_text_color":"000000","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/561673362124980225\/7royiINt_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/561673362124980225\/7royiINt_normal.png","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/3005559517\/1423880389","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/YHInvBCk4m","expanded_url":"http:\/\/marketparse.com","display_url":"marketparse.com","indices":[80,102]}],"user_mentions":[{"screen_name":"PinkSheetSutter","name":"Sue Sutter","id":155916518,"id_str":"155916518","indices":[0,16]}],"symbols":[{"text":"NVS","indices":[17,21]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1425671983663"}
{"created_at":"Fri Mar 06 15:52:45 +0000 2015","id":573873863005749248,"id_str":"573873863005749248","text":"RT @FierceBiotech: Novartis wins landmark approval for a biosimilar of Amgen's Neupogen. http:\/\/t.co\/ly2Y9UK6xz by @DamianFierce $NVS $AMGN","source":"\u003ca href=\"http:\/\/www.hootsuite.com\" rel=\"nofollow\"\u003eHootsuite\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":22797378,"id_str":"22797378","name":"AHIP Coverage","screen_name":"AHIPCoverage","location":"Washington, DC","url":"http:\/\/www.ahipcoverage.org","description":"America\u2019s Health Insurance Plans (AHIP) is the national trade association representing the health insurance industry.","protected":false,"verified":true,"followers_count":8465,"friends_count":1652,"listed_count":322,"favourites_count":31,"statuses_count":6367,"created_at":"Wed Mar 04 16:45:22 +0000 2009","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":true,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"FFFFFF","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/378800000024507051\/2f8f1823b591f4d60f2d3e636f77dead.png","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/378800000024507051\/2f8f1823b591f4d60f2d3e636f77dead.png","profile_background_tile":false,"profile_link_color":"084CA1","profile_sidebar_border_color":"000000","profile_sidebar_fill_color":"D2D2D2","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/507271769116266497\/c5-D4LOL_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/507271769116266497\/c5-D4LOL_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/22797378\/1409840248","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Fri Mar 06 14:36:52 +0000 2015","id":573854766654177280,"id_str":"573854766654177280","text":"Novartis wins landmark approval for a biosimilar of Amgen's Neupogen. http:\/\/t.co\/ly2Y9UK6xz by @DamianFierce $NVS $AMGN","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":18294197,"id_str":"18294197","name":"FierceBiotech","screen_name":"FierceBiotech","location":"Washington, DC","url":"http:\/\/FierceBiotech.com","description":"Tweets by the Fierce Life Sciences editorial team. Subscribe to our daily email newsletter at http:\/\/www.fiercebiotech.com\/offer\/signup","protected":false,"verified":false,"followers_count":39818,"friends_count":465,"listed_count":1235,"favourites_count":7,"statuses_count":15488,"created_at":"Sun Dec 21 22:21:58 +0000 2008","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"15184C","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"DB5E1F","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"EBEFC3","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2579189363\/5zktggp40a8nfj341ed2_normal.jpeg","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":6,"favorite_count":1,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/ly2Y9UK6xz","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/novartis-wins-landmark-approval-biosimilar-amgens-neupogen\/2015-03-06","display_url":"fiercebiotech.com\/story\/novartis\u2026","indices":[70,92]}],"user_mentions":[{"screen_name":"DamianFierce","name":"Damian Garde","id":529704495,"id_str":"529704495","indices":[96,109]}],"symbols":[{"text":"NVS","indices":[110,114]},{"text":"AMGN","indices":[115,120]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/ly2Y9UK6xz","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/novartis-wins-landmark-approval-biosimilar-amgens-neupogen\/2015-03-06","display_url":"fiercebiotech.com\/story\/novartis\u2026","indices":[89,111]}],"user_mentions":[{"screen_name":"FierceBiotech","name":"FierceBiotech","id":18294197,"id_str":"18294197","indices":[3,17]},{"screen_name":"DamianFierce","name":"Damian Garde","id":529704495,"id_str":"529704495","indices":[115,128]}],"symbols":[{"text":"NVS","indices":[129,133]},{"text":"AMGN","indices":[134,139]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1425657165658"}
{"created_at":"Fri Mar 06 20:31:52 +0000 2015","id":573944105044164608,"id_str":"573944105044164608","text":"$NVS wins approval for first U.S. #biosimilar drug - $AMGN seeking to block launch | @scoopit http:\/\/t.co\/aYf15s66fa","source":"\u003ca href=\"http:\/\/www.scoop.it\" rel=\"nofollow\"\u003eScoop.it\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2317848834,"id_str":"2317848834","name":"TwoFour Insight","screen_name":"TwoFourInsight","location":"Pitt | WashDC | New Delhi","url":"http:\/\/twofourinsight.com","description":"Regulatory and policy intelligence on US & India's life science market and industry. Clear Vision For The Life Sciences Industry - tweets \u2260 endorsement","protected":false,"verified":false,"followers_count":224,"friends_count":365,"listed_count":4,"favourites_count":21,"statuses_count":7532,"created_at":"Wed Jan 29 21:54:12 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/378800000177957343\/22zCd_pd.jpeg","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/378800000177957343\/22zCd_pd.jpeg","profile_background_tile":false,"profile_link_color":"326FA8","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/461865442202497024\/buZVqvLt_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/461865442202497024\/buZVqvLt_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/2317848834\/1391033200","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"biosimilar","indices":[34,45]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/aYf15s66fa","expanded_url":"http:\/\/sco.lt\/7cyGG1","display_url":"sco.lt\/7cyGG1","indices":[94,116]}],"user_mentions":[{"screen_name":"scoopit","name":"Scoop.it","id":209484168,"id_str":"209484168","indices":[85,93]}],"symbols":[{"text":"NVS","indices":[0,4]},{"text":"AMGN","indices":[53,58]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1425673912665"}
{"created_at":"Fri Mar 06 14:12:56 +0000 2015","id":573848743331561472,"id_str":"573848743331561472","text":"$AMGN News: \"FDA clears first biosimilar #premarket $NVS $AMGN \u2026\" http:\/\/t.co\/A8Y5uiXBqy Board view: https:\/\/t.co\/nTKakgvpGo","source":"\u003ca href=\"https:\/\/quantpost.com\" rel=\"nofollow\"\u003eQuantpost Herald\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1923926642,"id_str":"1923926642","name":"Quantpost Healthcare","screen_name":"QP_Health","location":"","url":"http:\/\/quantpost.com","description":"@Quantpost trade discovery reports updated in real-time for significant events in the Healthcare sector.","protected":false,"verified":false,"followers_count":156,"friends_count":158,"listed_count":10,"favourites_count":0,"statuses_count":3214,"created_at":"Tue Oct 01 16:23:15 +0000 2013","utc_offset":-25200,"time_zone":"Mountain Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"FFFFFF","profile_background_image_url":"http:\/\/pbs.twimg.com\/profile_background_images\/378800000086197972\/8400c43a4d4f8926bc84ddb373b8a88c.png","profile_background_image_url_https":"https:\/\/pbs.twimg.com\/profile_background_images\/378800000086197972\/8400c43a4d4f8926bc84ddb373b8a88c.png","profile_background_tile":true,"profile_link_color":"009999","profile_sidebar_border_color":"000000","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/513299812754538496\/AHXcCpDJ_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/513299812754538496\/AHXcCpDJ_normal.png","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/1923926642\/1411215198","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"premarket","indices":[41,51]}],"trends":[],"urls":[{"url":"http:\/\/t.co\/A8Y5uiXBqy","expanded_url":"http:\/\/seekingalpha.com\/news\/2351926-fda-clears-first-biosimilar?source=feed_f","display_url":"seekingalpha.com\/news\/2351926-f\u2026","indices":[66,88]},{"url":"https:\/\/t.co\/nTKakgvpGo","expanded_url":"https:\/\/quantpost.com\/list\/?symbol=AMGN","display_url":"quantpost.com\/list\/?symbol=A\u2026","indices":[101,124]}],"user_mentions":[],"symbols":[{"text":"AMGN","indices":[0,5]},{"text":"NVS","indices":[52,56]},{"text":"AMGN","indices":[57,62]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1425651176661"}
